Net sales and profits declined sharply year-over-year, with significant drops in Energy Materials and Life & Healthcare segments. Full-year guidance is unchanged, and the sale of a subsidiary will result in an extraordinary loss.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.